Gh. Vanzanten et al., RECOMBINANT LEECH ANTIPLATELET PROTEIN SPECIFICALLY BLOCKS PLATELET DEPOSITION ON COLLAGEN SURFACES UNDER FLOW CONDITIONS, Arteriosclerosis, thrombosis, and vascular biology, 15(9), 1995, pp. 1424-1431
Salivary glands of the leech Haementeria officinalis contain a protein
, leech antiplatelet protein (LAPP). This protein was cloned and expre
ssed in yeast and blocks collagen-mediated platelet aggregation and th
e adhesion of platelets to collagen-coated plates under static conditi
ons. In the current study we investigated the effect of rLAPP on plate
let deposition to collagen and collagen-rich surfaces under flow condi
tions. rLAPP completely inhibited platelet adhesion on collagen types
I, III, and IV with IC50 values of 70, 600, and 90 nmol/L, respectivel
y (shear rate=1600 s(-1)). Approximately 10-fold more rLAPP was requir
ed to obtain a similar inhibition at a low shear rate of 375 s(-1). rL
APP caused a concentration-dependent inhibition of binding of I-125-vo
n Willebrand factor (VWF) to collagen type III and was able to displac
e prebound VWF even after 24 hours. Since platelet adhesion at low she
ar rate is less dependent on VWF than at high shear rate, this propert
y of rLAPP may explain why less rLAPP is needed at high shear rate tha
n at low shear rate to produce the same effect. Platelet adhesion to c
ollagen type VI was only partially inhibited by rLAPP (maximal 44% wit
h 3 mu mol/L rLAPP). rLAPP also caused a pronounced inhibition of plat
elet deposition to cross sections of human atherosclerotic coronary ar
teries but had no effect on matrices of cultured human umbilical vein
endothelial cells. rLAPP is a potent platelet adhesion inhibitor at hi
gh shear rate, which binds to collagen and works by inhibiting binding
of vWF to collagen.